As of December 31, 2024, Facephi Biometria SA carries a market capitalization of 42.11M, placing it among publicly traded companies globally. Its enterprise value stands at 46.59M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 42.11M |
| Enterprise Value | 46.59M |
Facephi Biometria SA's next confirmed earnings release is scheduled for October 22, 2026.
| Earnings Date | 10/22/2026 |
As of December 31, 2024, Facephi Biometria SA has 25.21M shares outstanding.
| Shares Outstanding | 25.21M |
These figures are as of December 31, 2024.
| PB Ratio | 2.19 |
| P/TBV Ratio | 5.69 |
As of December 31, 2024, Facephi Biometria SA maintains a current ratio of 1.08, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.08 |
| Quick Ratio | 0.21 |
| Debt / Equity | 53.02 |
These figures cover the twelve months ended December 31, 2024.
| Employee Count | 248.50 |
As of the close on October 22, 2026, Facephi Biometria SA's stock has declined approximately 24.80% over the past 52 weeks. The 50-day moving average sits at 1.71, while the 200-day moving average is 2.05.
| 52-Week Price Change | -24.80% |
| 50-Day Moving Average | 1.71 |
| 200-Day Moving Average | 2.05 |
As of December 31, 2024, Facephi Biometria SA holds 5.70M in cash and equivalents against 10.18M in total debt, resulting in a net debt position of 4.56M. Total book value stands at 19.19M, with working capital of 2.05M providing operational flexibility.
| Cash & Cash Equivalents | 5.70M |
| Total Debt | 10.18M |
| Net Debt | 4.56M |
| Equity (Book Value) | 19.19M |
| Book Value Per Share | 0.76 |
| Working Capital | 2.05M |
Already premium?